Author

T. Maity

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Cultraro· 1 shared C. Wu· 1 shared F. Kirkali· 1 shared J. Cowart· 1 shared K. D. Nguyen· 1 shared K. Prasad· 1 shared K. Ross· 1 shared P. B. Shinde· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Cultraro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Facile Alternative Sustainable Process for the Extraction and Purification of Microbial Melanin

V. A. Ghadge, P. Kumar, T. Maity, K. Prasad, P. B. Shinde

This paper introduces a sustainable method using tetrabutylammonium hydroxide to extract and purify microbial melanin from Streptomyces hyderabadensis, achieving higher yields and recyclability compared to conventional methods.

bioRxiv · May 10, 2021 · PreprintMicrobiology

Global proteome and phosphoproteome alterations in third generation EGFR TKI resistance reveal drug targets to circumvent resistance

X. Zhang, T. Maity, K. Ross, Y. Qi, C. Cultraro, S. Gao, K. D. Nguyen, J. Cowart, F. Kirkali, C. Wu, U. Guha

The paper analyzes proteome and phosphoproteome changes in EGFR TKI-resistant lung cancer cells to identify drug targets that can overcome resistance.

bioRxiv · Jul 4, 2020Cancer Biology